Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pergoveris Regimens in Women 36-40 Undergoing ART
NCT01297465Phase 3Completed
- Sponsor
- Merck KGaA
- Start
- May 2011
- Primary completion
- Oct 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 11
01
Overview
A Phase 3 trial of luteinizing hormone in infertility, sponsored by Merck KGaA. Started May 2011; status: completed.
02
Drugs
luteinizing hormone
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01297465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01297465.